Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL3365803

Cc1ccc([I+]c2ccc3ccc(=O)oc3c2)cc1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.44
CA1 P00915 4/20 0.44
CA9 Q16790 4/20 0.44
ALDH1A1 P00352 5/20 0.42
DRD2 P14416 2/20 0.41
DRD4 P21917 2/20 0.41
KMT2A Q03164 4/20 0.41
GBA1 P04062 1/20 0.41
KDM4E B2RXH2 5/20 0.40
GLA P06280 5/20 0.40
GAA P10253 5/20 0.40
MAPT P10636 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.38
AKR1B1 P15121 2/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
MEN1 O00255 2/20 0.38
PKM P14618 2/20 0.38
CA3 P07451 1/20 0.38
CA4 P22748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL3367262 0.92 CA12 (0.42) CA12CA1CA9ALDH1A1DRD4
Trifluoromethanesulfonic Acid SCHEMBL3367494 0.89 MAOB (0.43) CA12CA1CA9ALDH1A1DRD2
SCHEMBL3371666 0.87 CA12 (0.48) CA12CA1CA9ALDH1A1DRD2
SCHEMBL3371435 0.86 CA12 (0.49) CA12CA1CA9ALDH1A1DRD2
SCHEMBL3370844 0.83 CA12 (0.45) CA12CA1CA9ALDH1A1DRD2
SCHEMBL3370953 0.80 GLA (0.37) CA12CA1CA9ALDH1A1DRD4
Trifluoromethanesulfonic Acid SCHEMBL3517953 0.80 CA12 (0.44) CA12CA1CA9ALDH1A1DRD2
Toliodium SCHEMBL2898696 0.79 GPR3 (0.44) CA12CA1CA9ALDH1A1KMT2A
SCHEMBL3371457 0.79 GLA (0.36) CA12CA1CA9ALDH1A1DRD4
SCHEMBL3370898 0.79 ALDH1A1 (0.43) CA12CA1CA9ALDH1A1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7833691-B2 Heterocycle-bearing onium salts WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-11-16 US disclosed
EP-1953149-B1 A heterocycle-containing onium salt WAKO PURE CHEM IND LTD (JP) 2010-10-06 EP disclosed
EP-1953149-A2 A heterocycle-containing onium salt Wako Pure Chemical Industries, Ltd. (JP) 2008-08-06 EP disclosed
US-20080161520-A1 Heterocycle-bearing onium salts WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2008-07-03 US disclosed
US-7318991-B2 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2008-01-15 US disclosed
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) 2005-10-20 US disclosed
EP-1481973-A1 HETEROCYCLE-BEARING ONIUM SALTS Wako Pure Chemical Industries, Ltd. (JP) 2004-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether NOX4, CBR1, CBR3 CA12 3023/4885CA1 1267/4885CA9 704/4885
US-20080161520-A1 Heterocycle-bearing onium salts MCM5, NIT2, PCNA CA12 2139/4885CA1 1258/4885CA9 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.